Shares of Synairgen plc (LON:SNG – Get Rating) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 24.38 ($0.28) and traded as low as GBX 17.20 ($0.20). Synairgen shares last traded at GBX 17.66 ($0.20), with a volume of 447,866 shares changing hands.

Synairgen Stock Down 1.9 %

The firm's fifty day moving average price is GBX 19.57 and its two-hundred day moving average price is GBX 24.38. The stock has a market cap of £35.55 million and a price-to-earnings ratio of -0.73. The company has a debt-to-equity ratio of 0.09, a current ratio of 6.35 and a quick ratio of 6.35.

About Synairgen

(Get Rating)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.

Further Reading

• MarketBeat: Week in Review 11/7 – 11/11
• Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
• Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
• Six Flags is a Ride You Don't Want to Get Stuck On
• Hanesbrands May be Signaling a Bad Week for Retail Stocks

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.